IIM
CATX icon

INTECH Investment Management’s Perspective Therapeutics CATX Stock Holding History

INTECH Investment Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.1K Buy
24,370
+4,863
+25% +$18.4K ﹤0.01% 1978
2026
Q1 		$81.3K Sell
19,507
-6,195
-24% -$26.2K ﹤0.01% 1930
2025
Q4 		$70.7K Sell
25,702
-4,222
-14% -$12K ﹤0.01% 2221
2025
Q3 		$103K Sell
29,924
-9,098
-23% -$33.2K ﹤0.01% 2257
2025
Q2 		$134K Buy
39,022
+282
+0.7% +$744 ﹤0.01% 2214
2025
Q1 		$82.5K Buy
38,740
+12,156
+46% +$36.5K ﹤0.01% 2356
2024
Q4 		$84.8K Buy
26,584
+16,295
+158% +$133K ﹤0.01% 2249
2024
Q3 		$137K Buy
+10,289
New +$137K ﹤0.01% 1824

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

INTECH Investment Management's CATX Position: Q2 2026 in Review

INTECH Investment Management increased its Perspective Therapeutics (CATX) stake by 25% in Q2 2026, buying an estimated $18.4K and bringing the position to 24,370 shares worth $83.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

INTECH Investment Management first reported a position in CATX in Q3 2024 and has held it in 8 quarters since. The position peaked at $137K in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • INTECH Investment Management held 24,370 shares of Perspective Therapeutics worth $83.1K as of Q2 2026.
  • INTECH Investment Management bought 4,863 Perspective Therapeutics shares in Q2 2026, an estimated $18.4K.
  • Perspective Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1978 holding.
  • INTECH Investment Management first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Perspective Therapeutics position peaked at $137K in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.